Top compounds associated with response to OR9A2


Feature Type Standardized
Nominal ANOVA
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA IU1 CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.14 0.004
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.072 0.02
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.088 0.02
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.075 0.02
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.11 0.02
Download CSV